Masimo Corp (MASI) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Apr 04 2026 to Mar 29 2025 - CSIMarket
CSIMarket
 


Masimo Corp  (NASDAQ: MASI)


Masimo's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Masimo's ROI in the first quarter of 2026?
Masimo Corp achieved a return on average invested assets (ROI) of 5.17 % in its first quarter of 2026, which is below Masimo's average return on investment, which stands at 11.19%.

Despite the deterioration in its net income, company has improved ROI compared to the fourth quarter of 2025.

Within the Healthcare sector 149 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Apr 04 2026 quarter, so far to 1071, from total ROI ranking in the fourth quarter of 2025 at 2771.

Definition and Formula of Return on Investment



Return On Investment (Apr 04 2026)
I. Quarter
(Jan 03 2026)
IV. Quarter
(Sep 27 2025)
III. Quarter
(Jun 28 2025)
II. Quarter
(Mar 29 2025)
I. Quarter
Y / Y Investment Change TTM -36.57 % -36.76 % -20.17 % -9.56 % -4.92 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,317 1,327 1,448 1,811 1,747
Return On Investment (TTM) 5.17 % -9.57 % -29.33 % -20.95 % -21.25 %
MASI's Overall Ranking # 1071 # 2771 # 3323 # 3020 # 3153
Seq. Investment Change TTM -6.78 % -18.47 % -11.43 % -5.77 % -7.06 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 76 -152 -569 -459 -494




Return On Investment MASI's Ranking
Within: No.
Industry # 41
Sector # 150
Overall # 1071

Return On Investment Statistics
High Average Low
31.65 %
11.19 %
-32.48 %
(March 31, 2016)  



  News about Masimo Corp Return on Investment ROI

Masimo Welcomes Bob Chapek, Former Disney CEO, to Its Board of Directors: A Promising Collaboration in the Healthcare Industry

January 16, 2024


In an exciting development, Masimo Corporation (NASDAQ: MASI) has recently announced the appointment of Bob Chapek to its Board of Directors. Chapek is renowned for his successful tenure as the Chief Executive Officer of The Walt Disney Company from February 2020 to November 2022. During his leadership, Chapek effectively steered Disney through the challenging times brought about by the global COVID-19 pandemic and played a crucial role in the company s recovery.
Under Chapek s guidance, Disney implemented strategic realignments within its media and entertainment divisions, significantly expanded its scale, and focused on growth prospects. His experience and expertise in navigating transformative periods will undoubtedly be invaluable to Masimo, a leading player in the healthcare industry.






Financial Statements
Masimo's I. Quarter Investments $ 1,317 Millions MASI's Balance sheet
Masimo's I. Quarter Income $ 57 Millions Quarterly MASI's Income Statement
MASI's Income by Division See MASI's Income by Division


MASI Annual Return On Investment (Jan 03 2026)
2025
(Dec 28 2024)
2024
(Dec 30 2023)
2023
(Dec 31 2022)
2022
(Jan 01 2022)
2021
Total Investments in Millions 1,327 2,008 2,478 2,581 1,619
Y / Y Investment Growth -33.9 % -18.96 % -3.99 % 59.37 % 9.51 %
Net Income in Millions -152 -305 82 144 230
Y / Y Net Income Growth - - -43.21 % -37.51 % -4.43 %
Annual Return On Investment -11.41 % -15.18 % 3.29 % 5.56 % 14.18 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MASI's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MASI's Competitors
Subscribers only: Roi for Masimo's Suppliers
Subscribers only: Return On Investment for MASI's Customers

Other Ratios
MASI's Roa MASI's Inventory Turnover Ratio MASI's Growth Rates MASI's Dividend Statistics
MASI's Profitability Ratios MASI's Asset Turnover Ratio MASI's Dividend Growth
MASI's Roe MASI's Valuation Ratios MASI's Financial Strength Ratios MASI's Dividend Payout Ratio



Companies with similar Return On Investment at Apr 04 2026, within Healthcare Sector ROI
Lifevantage Corp  13.20 %
Harmony Biosciences Holdings inc   13.07 %
Sbc Medical Group Holdings Incorporated  13.05 %
Johnson and Johnson  13.01 %
Progyny Inc   12.72 %
Universal Health Services Inc   12.68 %
Insulet Corporation  12.55 %
Encompass Health Corporation  12.43 %
Globus Medical Inc   12.37 %
Regeneron Pharmaceuticals Inc   12.19 %
Medinotec Inc   12.13 %
Msa Safety Inc  12.11 %
Healthcare Services Group Inc   12.09 %
Amgen Inc   12.04 %
Alpha Pro Tech Ltd   11.97 %
Kiniksa Pharmaceuticals International Plc  11.92 %
Prestige Consumer Healthcare Inc   11.89 %
Mimedx Group Inc   11.75 %
Ufp Technologies Inc   11.69 %
Ligand Pharmaceuticals Incorporated  11.46 %
Cryoport inc   11.23 %
Solventum Corporation  11.19 %
Nature s Sunshine Products inc   11.05 %
Bristol myers Squibb Company  10.72 %
Lemaitre Vascular Inc   10.60 %
Dr Reddy s Laboratories Limited  10.30 %
Siga Technologies Inc  10.04 %
Align Technology inc   9.99 %
Boston Scientific Corporation  9.95 %
Pacific Health Care Organization Inc  9.95 %


Date modified: 2026-09-26T07:16:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.